PET Drugs cGMP Proposed Rule, Guidance To Be Refined By CDER
This article was originally published in The Gray Sheet
Executive Summary
FDA plans to clarify the quality control section of its preliminary draft proposed rule and proposed guidance for positron emission tomography (PET) radiopharmaceutical current good manufacturing practices